Avalon GloboCare Corp. Cash Flow Conversion Efficiency
Avalon GloboCare Corp. cash flow conversion efficiency. Based on the latest financial reports, Avalon GloboCare Corp. (ALBT) has a cash flow conversion efficiency ratio of -0.069x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-695.68K) by net assets ($10.07 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Avalon GloboCare Corp. (2015–2025)
Cash flow conversion efficiency of Avalon GloboCare Corp. from 2015 to 2025. This chart illustrates how Avalon GloboCare Corp.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Avalon GloboCare Corp. stock price today for real-time trading data and today's change.
Avalon GloboCare Corp. Cash Flow Conversion Ratio Explained
Avalon GloboCare Corp. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Avalon GloboCare Corp. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Avalon GloboCare Corp. ranked by their cash flow conversion efficiency. Also see Avalon GloboCare Corp. (ALBT) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Global Sukses Solusi Tbk PT
JK:RUNS
|
-0.002x |
|
Pearl Polymers Limited
NSE:PEARLPOLY
|
-0.121x |
|
BLAZE Minerals Ltd
AU:BLZ
|
-0.126x |
|
Freehill Mining Ltd
AU:FHS
|
-0.067x |
|
Silla Sg Co. Ltd
KQ:025870
|
0.474x |
|
Biotricity Inc
NASDAQ:BTCY
|
-0.013x |
|
Atlantic Sapphire As
OL:ASA
|
-2.484x |
|
Zotefoams PLC
LSE:ZTF
|
0.044x |
Annual Cash Flow Conversion Efficiency for Avalon GloboCare Corp. (2015–2025)
The table below shows the annual cash flow conversion efficiency of Avalon GloboCare Corp. from 2015 to 2025. Review Avalon GloboCare Corp. (ALBT) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $9.23 Million | $-4.99 Million | -0.540x | +22.76% |
| 2024-12-31 | $7.10 Million | $-4.97 Million | -0.700x | +20.74% |
| 2023-12-31 | $7.37 Million | $-6.50 Million | -0.883x | -39.98% |
| 2022-12-31 | $11.16 Million | $-7.04 Million | -0.631x | +61.29% |
| 2021-12-31 | $3.08 Million | $-5.02 Million | -1.629x | +11.13% |
| 2020-12-31 | $4.12 Million | $-7.55 Million | -1.833x | -15.60% |
| 2019-12-31 | $4.47 Million | $-7.08 Million | -1.586x | -305.92% |
| 2018-12-31 | $11.25 Million | $-4.40 Million | -0.391x | -113.11% |
| 2017-12-31 | $7.31 Million | $-1.34 Million | -0.183x | -4748.22% |
| 2016-12-31 | $3.55 Million | $13.98K | 0.004x | -99.93% |
| 2015-12-31 | $-5.41K | $-30.11K | 5.569x | -- |
About Avalon GloboCare Corp.
Avalon GloboCare Corp., together with its subsidiaries, develops innovative artificial intelligence platforms in the United States and China. It operates through Consumer Health Technology and Artificial Intelligence Content Technology Segment. The company offers automated video generation, enterprise documentation, and workflow automation solutions, as well as cellular therapy and generative AI … Read more